Floatz logo

1,379 assets in Cancer

Therapeutic assets addressing Cancer, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
gh2616 tablets
Cancer
Suzhou Genhouse Bio Co., Ltd.P1C (36)
Grc 54276
Cancer
Glenmark Specialty S.A.P1C (36)
gs-0201
Cancer
Gilead SciencesP1C (36)
gs-2121
Cancer
Gilead SciencesP1C (36)
gs-2426
Cancer
Gilead SciencesP1C (36)
gs-5319
Cancer
Gilead SciencesP1C (36)
Gtb-5550
Cancer
Masonic Cancer Center, University of MinnesotaP1C (36)
h1710 for
Cancer
Shenzhen Hepalink Pharmaceutical Group Co., Ltd.P1C (36)
hb0030
Cancer
Huabo Biopharm Co., Ltd.P1C (36)
Hbt-708
Cancer
Shenyang Sunshine Pharmaceutical Co., LTD.P1C (36)
hc010
Cancer
HC Biopharma Inc.P1C (36)
hcb101
Cancer
FBD Biologics LimitedP1C (36)
hcb301
Cancer
FBD Biologics LimitedP1C (36)
hdm2005
Cancer
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.P1C (36)
hdm2006
Cancer
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.P1C (36)
hdm2017
Cancer
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.P1C (36)
hdm2024
Cancer
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.P1C (36)
Hemay181
Cancer
Ganzhou Hemay Pharmaceutical Co., LtdP1C (36)
hg381
Cancer
HitGen Inc.P1C (36)
hlx23
Cancer
Shanghai Henlius BiotechP1C (36)
Hrs-3802
Cancer
Shandong Suncadia Medicine Co., Ltd.P1C (36)
Hrs-4508
Cancer
Jiangsu HengRui Medicine Co., Ltd.P1C (36)
Hrs-6209
Cancer
Jiangsu HengRui Medicine Co., Ltd.P1C (36)
Hrxg-K-1939
Cancer
Fudan UniversityP1C (36)
hs-10381
Cancer
Jiangsu Hansoh Pharmaceutical Co., Ltd.P1C (36)
hs-10386
Cancer
Jiangsu Hansoh Pharmaceutical Co., Ltd.P1C (36)
hs-20089
Cancer
Hansoh BioMedical R&D CompanyP1C (36)
hs-20108 monotherapy
Cancer
Hansoh BioMedical R&D CompanyP1C (36)
hs-20117
Cancer
Jiangsu Hansoh Pharmaceutical Co., Ltd.P1C (36)
hs-20122
Cancer
Hansoh BioMedical R&D CompanyP1C (36)
hs269
Cancer
Zhejiang Hisun Pharmaceutical Co. Ltd.P1C (36)
hsk41959
Cancer
Haisco Pharmaceutical Group Co., Ltd.P1C (36)
hv-101
Cancer
Hervor TherapeuticsP1C (36)
hw071021 tablets
Cancer
Wuhan Humanwell Innovative Drug Research and Development Center Limited CompanyP1C (36)
hws116
Cancer
Wuhan Humanwell Innovative Drug Research and Development Center Limited CompanyP1C (36)
hy-0102
Cancer
Shanghai YingLi Pharmaceutical Co. Ltd.P1C (36)
Ibi 389
Cancer
Innovent Biologics (Suzhou) Co. Ltd.P1C (36)
il12-l19l19
Cancer
Philogen S.p.A.P1C (36)
ilb2109
Cancer
Innolake BiopharmP1C (36)
Ilb-3101
Cancer
Innolake BiopharmP1C (36)
imc008
Cancer
Changhai HospitalP1C (36)
imm2520
Cancer
ImmuneOnco Biopharmaceuticals (Shanghai) Inc.P1C (36)
imm27m
Cancer
ImmuneOnco Biopharmaceuticals (Shanghai) Inc.P1C (36)
Immunoglobulin G1 [301-Alanine,De-C-Terminal-Lysine], Anti-(Human Cd73 Antigen) (Human-Mus Musculus Monoclonal Inca00186 ?1-Chain), Disulfide With Human-Mus Musculus Monoclonal Inca00186 ?-Chain, Dimer
Cancer
Incyte CorporationP1C (36)
Immunoglobulin G1, Anti-(Human Cc Chemokine Receptor Ccr8) (Human Monoclonal Bay 3375968 ?1-Chain), Disulfide With Human Monoclonal Bay 3375968 ?-Chain, Dimer
Cancer
BayerP1C (36)
Immunoglobulin G1, Anti-(Human Cc Chemokine Receptor Ccr8) (Human Monoclonal Chs114 ?1-Chain), Disulfide With Human Monoclonal Chs114 ?-Chain, Dimer
Cancer
Coherus Oncology, Inc.P1C (36)
Immunoglobulin G1 [De-451-Lysine], Anti-(Human/Macaca Fascicularis/Macaca Mulatta/Chlorocebus Sabaeus Mhc Class I Chain-Related Protein Mica/Mhc Class I Chain-Related Protein Micb) (Human-Mus Musculus Monoclonal Cln-619 ?1-Chain), Disulfide With Human-Mus Musculus Monoclonal Cln-619 [34-Leucine] ?-Chain, Dimer
Cancer
Cullinan Therapeutics Inc.P1C (36)
Immunoglobulin G1-Kappa, Anti-[Homo Sapiens Cldn6 (Claudin 6, Claudin-6)], Monoclonal Antibody (Ixotatug)
Cancer
TORL Biotherapeutics, LLCP1C (36)
Immunoglobulin G1-Kappa, Anti-(Homo Sapiens Tyrosine-Protein Kinase Receptor Ufo (Axl Oncogene; Ec=2.7.10.1)); Humanized Monoclonal Antibody Conjugated To The Pyrrolobenzodiazepine (Pdb) Dimer, Sg3199; .Gamma.1 Heavy Chain Humanized (1-451) (Vh Humanized (Homo Sapiens Ighv3-30*03 (93%)-(Ighd)-Ighj4*01 (92%)) (8.8.15) (1-122) Homo Sapiens Ighg1*03 (Ch1(R97>K(219)), Ch3(K107>Del(452))) (123-451)), (225-215')-Disulfide With .Kappa. Light Chain Humanized (1'-215') (Humanized V-Kappa (Homo Sapiens Igkv3-11*01 (84%)-Igkj4*01 (91%))(7.3.9) (1'-108')-Homo Sapiens Igkc*01 (109'-215')); Dimer (231-231'':234-234'')-Bisdisulfide, Produced In Chinese Cho Cells, Glycoform Alfa; Conjugated On The Two Glycoengineered Asn-302 And Asn-302'', Via A Spacer And Cleavable Valyl-Alanyl Linker, To The Cytotoxic Pyrrolobenzodiazepine (Pbd) Dimer, Sg3199
Cancer
ADC Therapeutics S.A.P1C (36)
Inavolisib
Cancer
Genentech, Inc.P1C (36)
Showing 1001 to 1050 of 1,379 assets
PreviousPage 21 of 28Next